Porphyrin photosensitizers in photodynamic therapy and its applications
- PMID: 29113417
 - PMCID: PMC5655312
 - DOI: 10.18632/oncotarget.20189
 
Porphyrin photosensitizers in photodynamic therapy and its applications
Abstract
In 1841, the extraction of hematoporphyrin from dried blood by removing iron marked the birth of the photosensitizer. The last twenty years has witnessed extensive research in the application of photodynamic therapy (PDT) in tumor-bearing (or other diseases) animal models and patients. The period has seen development of photosensitizers from the first to the third generation, and their evolution from simple to more complex entities. This review focuses on porphyrin photosensitizers and their effect on tumors, mediated via several pathways involved in cell necrosis, apoptosis or autophagic cell death, and the preventive and therapeutic application of PDT against atherosclerosis.
Keywords: application; photodynamic therapy; porphyrin photosensitizers; tumor.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Figures
References
- 
    
- Lee DK, Choi Y, Shon SM, Schellingerhout D, Park JE, Kim DE. Atorvastatin and clopidogrel interfere with photosensitization in vitro. Photochem Photobiol Sci. 2011;10:1587–1592. - PubMed
 
 - 
    
- Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B. 1997;39:1–18. - PubMed
 
 - 
    
- Plonka J, Latocha M. Photodynamic therapy in the treatment of breast cancer. Pol Merkur Lekarski. 2012;33:173–175. - PubMed
 
 
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
              